Protein A-immunoadsorption in chemotherapy associated hemolytic-uremic syndrome

Transfusion Science

Volumn 19, Issue SUPPL., 1997, Pages 5-7

  Borghardt, E J ^a   Kirchertz, E J ^a   Marten, I ^a   Fenchel, K ^a  

^a Medical Clinic I   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; MITOMYCIN C; PROTEIN A;

ANTIGEN ANTIBODY COMPLEX; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; HEMOLYTIC UREMIC SYNDROME; HUMAN; IMMUNOADSORPTION; NEOPLASM; PATIENT; PLASMA VOLUME; PLASMAPHERESIS;

EID: 0031929352     PISSN: 09553886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-3886(97)00097-0     Document Type: Conference Paper

References (15)

1. Murgo AJ: Thrombotic microangiopathy in the cancer patient including those induced by chemotherapeutic agents. Semin Hematol 1987; 24:161-177.
2. Lesesne JB, Rothschild N, Erickson B, et al.: Cancer-associated hemolytic-uremic syndrome: Analysis of 85 cases from a national registry. J Clin Oncol 1989; 7:781-789.
3. Borghardt EJ, Nagel GA: Behandlung des tumor-assoziierten hämolytischurämischen Syndroms mit Protein-A-Immunabsorption, In Nagel GA, Bach F, Bartsch H-H, (eds). Aktuelle Onkologie 28 - Mitomycin '85 Klinik, Pharmakologie, Perspektive. München, W. Zuckschwerdt Verlag,1986, pp. 241-247.
4. Charba D, Moake JL, Harris ML, Hester JP: Abnormalities of von Willebrand factor multimers in drug-associated thrombotic microangiopathies. Am J Hematol 1993; 42:268-277.
5. Habib R: Pathology of the hemolytic uremic syndrome, in Kaplan BS, Trompeter RS, Moake JL, (eds), Hemolytic-uremic Syndrome and Thiombotic Thiombocytopenic Purpura. New York, Marcel Dekker, 1992,315-353.
6. Neame PB: Immunologic and other factors in thrombotic thrombocytopenic purpura (TTP). Semin Thromb Hemost 1980; 6:416-429.
7. Pfueller SL, David R, Firkin BG, et al.: Platelet aggregating IgG antibody to platelet surface glycoproteins associated with thrombosis and thrombocytopenia. Br J Haematol 1990; 74:336-341.
8. Meister RJ, Sacker RA, Phillips T: Immune complexes in thrombotic thrombocytopenic purpura. Ann Intern Med 1979; 90:717.
9. Cantrell JE, Phillips TM, Smith FP, Schein PS: Immune complex analysis and plasmapheresis in cancer related thrombotic thrombocytopenic purpura (TTP)/hemolytic uremic syndrome (HUS). Blood 1982; 60:185a.
10. Korec S, Schein PS, Smith FP, et al.: Treatment of cancer-associated hemolytic uremic syndrome with staphylococcal protein A immunoperfusion. J Clin Oncol 1986; 4:210-215.
11. Shepard KV, Bukowski RM: The treatment of Thrombotic Thrombocytopenic Purpura with exchange transfusions, plasma infusions, and plasma exchange. Semin Hematol 1987; 24:178-193.
12. Borghardt EJ: Chemotherapie-induziertes Hämolytisch-urämisches Syndrom, in Schmoll HJ, Höffken K, Possinger K, (eds), Kompendium Internistische Onkoloe Band II, Berlin, Springer-Verlag, 1997, pp. 1987-1190.
13. Chow S, Roscoe J, Cattran DC: Plasmapheresis and antiplatelets agents in treatment of the hemolytic uremic syndrome secondary to mitomycin. Am J Kidney Dis 1986; 7:407-412.
14. Snyder HW, Mittelman A, Oral A, Messerschmidt GL: Treatment of cancer chemotherapy-associated thrombotic thrombocytopenic purpura/hemolyc uremic syndrome by protein A immunoadsorption of plasma. Cancer 1993; 71:1882-1892.
15. Benny B: Therapeutic protein A immunoadsorption - a brief review. CSTM Bullentin 1996; 8:16.